FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

29973411000001106: Ondansetron 4mg orodispersible tablets (Sigma Pharmaceuticals Plc) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 19-Aug 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
93581101000001113 Ondansetron 4mg orodispersible tablets (Sigma Pharmaceuticals Plc) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
93581201000001118 Ondansetron 4mg orodispersible tablets (Sigma Pharmaceuticals Plc) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ondansetron 4mg orodispersible tablets (Sigma Pharmaceuticals Plc) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ondansetron 4mg orodispersible tablets (Sigma Pharmaceuticals Plc) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Ondansetron 4mg orodispersible tablets (Sigma Pharmaceuticals Plc) Is a Ondansetron 4mg orodispersible tablets true Inferred relationship Existential restriction modifier
Ondansetron 4mg orodispersible tablets (Sigma Pharmaceuticals Plc) Is a Product containing precisely ondansetron (as ondansetron hydrochloride) 4 milligram/1 each conventional release orodispersible tablet (clinical drug) false Inferred relationship Existential restriction modifier
Ondansetron 4mg orodispersible tablets (Sigma Pharmaceuticals Plc) Has active ingredient Ondansetron true Inferred relationship Existential restriction modifier
Ondansetron 4mg orodispersible tablets (Sigma Pharmaceuticals Plc) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Ondansetron 4mg orodispersible tablets (Sigma Pharmaceuticals Plc) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ondansetron 4mg orodispersible tablets (Sigma Pharmaceuticals Plc) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Ondansetron 4mg orodispersible tablets (Sigma Pharmaceuticals Plc) Has specific active ingredient Ondansetron true Inferred relationship Existential restriction modifier
Ondansetron 4mg orodispersible tablets (Sigma Pharmaceuticals Plc) Has dispensed dose form Conventional release orodispersible tablet true Inferred relationship Existential restriction modifier
Ondansetron 4mg orodispersible tablets (Sigma Pharmaceuticals Plc) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Ondansetron 4mg orodispersible tablets (Sigma Pharmaceuticals Plc) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Ondansetron 4mg orodispersible tablets (Sigma Pharmaceuticals Plc) 10 tablet Has AMP True Ondansetron 4mg orodispersible tablets (Sigma Pharmaceuticals Plc) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start